The Europe Neurological Biomarkers Market would witness market growth of 13.7% CAGR during the forecast period (2022-2028).
With the recent development of neurological biomarkers found in blood, identifying and treating neurological diseases such as chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, autism, and major depressive disorder should become simpler. Recent developments in detection technology have made it possible to find neurological biomarkers in blood.
For instance, the Simoa (single-molecule array) technology from Quanterix increases sensitivity by digitizing the extremely effective ELISA (enzyme-linked immunosorbent test) method of measuring binding between two molecules. For the biomarker of interest, Quanterix screens patient samples using 720,000 microscopic beads covered with capture antibodies. The beads are then mixed with a fluorescent marker and spread out into 216,000 isolated microchambers.
The high signal-to-noise ratio results in very responsive detection. Numerous researchers use Quanterix's technology to evaluate biomarker quantities in both CSF and blood, with almost half of their current applications being related to neurology. One such is their work on CTE and concussion biomarkers. Mild concussions can cause brain damage without causing any symptoms, and the accumulation of multiple sub-concussive hits to the brain leads to the development of CTE.
Doctors in the UK informed the platforms of 153 unique instances that met the clinical case criteria during this time, which is comparable to the aggregate COVID-19 data from UK government public health organizations. Of the 153 patients, complete clinical data were available for 125 (82%) of them. In the UK, many people experience tinnitus, yet the illness is poorly understood and has no standard therapy. Tinnitus is thought to be brought on by aberrant nerve discharge patterns in the brain's hearing centers. These characteristics have led to a flourishing market for regional neurological biomarkers market.
The Germany market dominated the Europe Neurological Biomarkers Market by Country in 2021; thereby, achieving a market value of $822.7 Million by 2028. The UK market is experiencing a CAGR of 12.8% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 14.5% during (2022 - 2028).
Based on Type, the market is segmented into Proteomic, Genomic, Metabolomic and Others. Based on Application, the market is segmented into Alzheimer's Disease, Parkinson’s Disease and Multiple Sclerosis. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Neurological Biomarkers Market will Hit $12.9 Billion by 2028, at a CAGR of 14.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. HOFFMANN-LA ROCHE LTD., Bio-Rad Laboratories, Inc., Merck Group, PERKINELMER INC., Shimadzu corporation, Thermo Fisher Scientific, Inc., Quanterix Corporation, Neuro-Bio Ltd., BioMérieux S.A. and Myriad Genetics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Proteomic
- Genomic
- Metabolomic
- Others
By Application
- Alzheimer's Disease
- Parkinson’s Disease
- Multiple Sclerosis
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- F.HOFFMANN-LA ROCHE LTD.
- Bio-Rad Laboratories, Inc.
- Merck Group
- PERKINELMER INC.
- Shimadzu corporation
- Thermo Fisher Scientific, Inc.
- Quanterix Corporation
- Neuro-Bio Ltd.
- BioMérieux S.A.
- Myriad Genetics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Neurological Biomarkers Market, by Type
1.4.2 Europe Neurological Biomarkers Market, by Application
1.4.3 Europe Neurological Biomarkers Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Neurological Biomarkers Market by Type
3.1 Europe Proteomic Market by Country
3.2 Europe Genomic Market by Country
3.3 Europe Metabolomic Market by Country
3.4 Europe Others Market by Country
Chapter 4. Europe Neurological Biomarkers Market by Application
4.1 Europe Alzheimer's Disease Market by Country
4.2 Europe Parkinson’s Disease Market by Country
4.3 Europe Multiple Sclerosis Market by Country
Chapter 5. Europe Neurological Biomarkers Market by Country
5.1 Germany Neurological Biomarkers Market
5.1.1 Germany Neurological Biomarkers Market by Type
5.1.2 Germany Neurological Biomarkers Market by Application
5.2 UK Neurological Biomarkers Market
5.2.1 UK Neurological Biomarkers Market by Type
5.2.2 UK Neurological Biomarkers Market by Application
5.3 France Neurological Biomarkers Market
5.3.1 France Neurological Biomarkers Market by Type
5.3.2 France Neurological Biomarkers Market by Application
5.4 Russia Neurological Biomarkers Market
5.4.1 Russia Neurological Biomarkers Market by Type
5.4.2 Russia Neurological Biomarkers Market by Application
5.5 Spain Neurological Biomarkers Market
5.5.1 Spain Neurological Biomarkers Market by Type
5.5.2 Spain Neurological Biomarkers Market by Application
5.6 Italy Neurological Biomarkers Market
5.6.1 Italy Neurological Biomarkers Market by Type
5.6.2 Italy Neurological Biomarkers Market by Application
5.7 Rest of Europe Neurological Biomarkers Market
5.7.1 Rest of Europe Neurological Biomarkers Market by Type
5.7.2 Rest of Europe Neurological Biomarkers Market by Application
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bio-Rad laboratories, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 Merck Group
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.4 PerkinElmer, Inc.
6.4.1 Company Overview
6.4.1 Financial Analysis
6.4.2 Segmental and Regional Analysis
6.4.3 Research & Development Expense
6.5 Shimadzu Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.6 Thermo Fisher Scientific, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 BioMérieux S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expenses
6.8 Myriad Genetics, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expenses
6.9 Quanterix Corporation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
6.9.5 Recent strategies and developments:
6.9.5.1 Partnerships, Collaborations, and Agreements:
6.10. Neuro-Bio Ltd.
6.10.1 Company Overview
TABLE 1 Europe Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 2 Europe Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 3 Europe Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 4 Europe Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 5 Europe Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Genomic Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Genomic Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 14 Europe Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 15 Europe Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Parkinson’s Disease Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Parkinson’s Disease Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 23 Germany Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 24 Germany Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 25 Germany Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 26 Germany Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 27 Germany Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 28 Germany Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 29 UK Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 30 UK Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 31 UK Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 32 UK Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 33 UK Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 34 UK Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 35 France Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 36 France Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 37 France Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 38 France Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 39 France Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 40 France Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 41 Russia Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 42 Russia Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 43 Russia Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 44 Russia Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 45 Russia Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 46 Russia Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 47 Spain Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 48 Spain Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 49 Spain Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 50 Spain Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 51 Spain Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 52 Spain Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 53 Italy Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 54 Italy Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 55 Italy Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 56 Italy Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 57 Italy Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 58 Italy Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 59 Rest of Europe Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 60 Rest of Europe Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 61 Rest of Europe Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 62 Rest of Europe Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 63 Rest of Europe Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 64 Rest of Europe Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 65 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 66 Key Information – Bio-Rad Laboratories, Inc.
TABLE 67 key Information – Merck GrouP
TABLE 68 key Information – PerkinElmer, Inc.
TABLE 69 Key Information – Shimadzu Corporation
TABLE 70 Key Information – Thermo Fisher Scientific, Inc.
TABLE 71 Key information – BioMérieux S.A.
TABLE 72 Key Information – Myriad Genetics, Inc.
TABLE 73 Key Information – QUANTERIX CORPORATION
TABLE 74 Key Information – Neuro-Bio Ltd.
List of Figures
FIG 1 Methodology for the research